Abstract
Bendamustine Followed By Ofatumumab and Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL): CLL2-BIO Trial of the German CLL Study Group (GCLLSG)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have